Continued Roche CAR-T partnership progress with agreement for Poseida to initiate Phase 1b portion of P-BCMA-ALLO1 clinical trial   Strong Astellas research collaboration momentum with nomination of first allogeneic solid tumor CAR-T program target On track to deliver meaningful clinical updates